Closed transaction

Sale of Allderma – a Swedish consumer healthcare company

Sale of Allderma to Avia Pharma

Advised by
Client
Counterparty
Deal stage
Closed transaction
Service
Sell
Sector
Healthcare
Sub-sector
Biotech/Pharma Services
Market
EMEA
Contact
henrik.westling@evli.com

Deal details

In February 2026 Allderma was sold to Avia Pharma, a European consumer healthcare platform owned by healthcare PE fund Impilo.

We have been invited to pitch for the sales mandate of Allderma https://allderma.se/ , a Swedish consumer healthcare company. Allderma has a strong position in certain segments of the Swedish dermatology market and mainly sells through pharmacies. Its strongest categories are dry scalp (https://daxxin.se/en/), nail fungus (https://terclara.se/), foot and hand warts (https://transversal.se/) and supplements for hair growth (https://www.baltex.se/varumarken/harkontroll). 2025 the company will have sales of approx. USD 15m with ca 17% EBITDA margin. During the last 4 years annual sales growth has been above 40% driven mainly by strong development of the dry scalp and nail fungus products. Around 90% of sales are generated in the Swedish market, but the company has recently started making inroads to the other Nordic markets. Especially the dry scalp and nail fungus products have good potential for expansion outside of the Nordics for a buyer with existing sales channels and market presence outside of the Nordics.

 

Henrik Westling Evli Corporate Finance AB Henrik joined Evli in May 2002 following Evli’s acquisition of Arthur Andersen’s Nordic Corporate Finance operations. View profile
Tom Eriksson Associate Evli Corporate Finance AB Associate at Evli Corporate Finance, having joined the firm in spring 2023. View profile

More by Evli Corporate Finance AB

More deals in Healthcare

Sell-side advisory

Allied Group has acquired majority stake in Tzamal Medical.

Where
Israel
Year
2026
Sell-side advisory

PharmaX Solutions was sold to BioPhorum.

Where
Germany
Year
2026
Sell-side advisory

Nostos Genomics was sold to Limbus Medical Technologies (varvis®).

Where
Germany
Year
2025
Sell-side advisory

NUTRIBRAIN was sold to LABORATORIOS RUBIÓ.

Where
Spain
Year
2025

More Healthcare

More deals in Europe

Sell-side advisory

Ocean Property Services Group sold to Lomond.

Where
United Kingdom
Year
2026
Advisory

John Henry Group.

Where
United Kingdom
Year
2026
Advisory

houzy and myky join forces under Swiss Digital Home AG.

Where
Switzerland
Year
2026
Sell-side advisory

Fibreactive sold to discoverIE Group plc.

Where
United Kingdom
Year
2026

More Europe

Membership

Gain worldwide reach with CapFive M&A professionals

The professionals of CapFive have been carefully selected on the basis of reputation, relationships, proven track record and knowledge of local markets.

Become a member

Get in touch

Find an adviser.

From a first valuation to signed completion, CapFive member firms advise on sell-side, buy-side, corporate finance and debt.

Share what you are planning and we will connect you with an adviser who has done it before, and who can bring in colleagues across borders when the deal needs them.

Contact us